HyperAcute Melanoma: Phase II data

Additional data from 16 patients with stage IV melanoma in an open-label, U.S. Phase II trial showed that HyperAcute Melanoma plus PegIntron peginterferon alfa-2b produced 2 complete responses, 2 cas...